Michael Walters
OpinionExempt from the chaos? What Trump’s tariff carve-out means for architects working in UK life sciences
Michael Walters sets out how the Trump administration’s apparent tariff exemption for pharmaceuticals could offer a unique opportunity for the life sciences sector